Reuters logo
BRIEF-Clementia Pharmaceuticals qtrly loss per share ‍$1.83​
November 13, 2017 / 1:18 PM / a month ago

BRIEF-Clementia Pharmaceuticals qtrly loss per share ‍$1.83​

Nov 13 (Reuters) - Clementia Pharmaceuticals Inc:

* Clementia Pharmaceuticals Inc - qtrly loss per share ‍$1.83​

* Clementia Pharmaceuticals Inc- ‍as of September 30, 2017, had cash and investments of $152.2 million​

* Clementia - ‍anticipates reporting preliminary results from part b open-label extension portion of phase ii study of palovarotene in fop in Q2 2018​

* Clementia Pharmaceuticals Inc- on track to begin move study protocol phase iii study and enroll first patient by end of 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below